Universidade Estadual Paulista (UNESP)
27/05/2014
01/10/2005
The background of prodrug design is presented herein as the basis for introducing new and advanced latent systems, taking into account mainly the versatility of polymers and other macromolecules as carriers. PDEPT (Polymer-Directed Enzyme Prodrug Therapy); PELT (Polymer-Enzyme Liposome Therapy); CDS (Chemical Delivery System); ADEPT(Antibody-Directed Enzyme Prodrug Therapy); GDEPT/VDEPT (Gene-Directed Enzyme Prodrug Therapy/Virus-Directed Enzyme Prodrug Therapy); ODDS (Osteotropic Drug Delivery System) and LEAPT (Lectin-directed enzyme-activated prodrug therapy) are briefly described and some examples are given. © 2005 Bentham Science Publishers Ltd.
893-914
http://dx.doi.org/10.2174/138955705774329528
Mini-Reviews in Medicinal Chemistry, v. 5, n. 10, p. 893-914, 2005.
1389-5575
http://hdl.handle.net/11449/68433
10.2174/138955705774329528
WOS:000231837000003
2-s2.0-24944549193
eng
Mini-Reviews in Medicinal Chemistry
closedAccess
info:eu-repo/semantics/review